Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma

Zhaoyun Liu,Yixuan Guo,Xiaohan Liu,Panpan Cao,Hui Liu,Xifeng Dong,Kai Ding,Rong Fu
DOI: https://doi.org/10.3390/cancers15010067
2022-01-01
Cancers
Abstract:Pim-2 kinase is overexpressed in multiple myeloma (MM) and is associated with poor prognosis in patients with MM. Changes in quantitative metabolism, glycolysis, and oxidative phosphorylation pathways are reportedly markers of all tumor cells. However, the relationship between Pim-2 and glycolysis in MM cells remains unclear. In the present study, we explored the relationship between Pim-2 and glycolysis. We found that Pim-2 inhibitors inhibited glycolysis and energy production in MM cells. Inhibition of Pim-2 decreased the proliferation of MM tumor cells and increased their susceptibility to apoptosis. Our data suggest that reduced Pim-2 expression inhibits the energy metabolism process in MM, thereby inhibiting tumor progression. Hence, Pim-2 is a potential metabolic target for MM treatment.
What problem does this paper attempt to address?